We analysed 56 diaries, 28 from women taking gamolenic acid and 28 from those taking placebo. All data were included in the analysis irrespective of any lack of compliance or protocol violation - that is, the analysis was conducted on an intention to treat basis. Eighteen women given gamolenic acid and 17 given placebo completed the trial.
The two groups were similar at baseline (table I). Table II shows the improvement in the number of episodes of flushing or sweating between the control cycle and the last available treatment cycle.